Wolverine Trading, LLC Recursion Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.92 - $8.6 $188,848 - $274,340	31,900 Added 45.77%	101,600 $669,000
Q2 2024 Aug 14, 2024	SELL	$7.35 - $10.05 $49,980 - $68,340	-6,800 Reduced 8.89%	69,700 $522,000
Q1 2024 May 15, 2024	BUY	$9.13 - $15.52 $512,193 - $870,672	56,100 Added 275.0%	76,500 $762,000
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $31,049 - $65,819	6,100 Added 42.66%	20,400 $201,000
Q3 2023 Nov 15, 2023	BUY	$6.59 - $15.86 $94,237 - $226,798	14,300 New	14,300 $109,000

289

242M

1.35M

2.32M

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.16B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.